Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Simply Solventless Concentrates Ltd. (TSXV: HASH) (OTC Pink: SSCLCF) ("SSC") is pleased to announce that it has ranked 14TH on the 2025 TSX Venture 50TM list. The 2025 TSX Venture 50TM list is a ranking of the top fifty performing companies on the TSXV over the prior year. The top 50 companies were ranked based on an equal weighting of 2024 share price appreciation, market capitalization increase, and trading volume between December 31, 2023, and December 31, 2024. SSC was the only licensed cannabis producer to make the TSX Venture 50TM list, with a share price appreciation of 420% and a market capitalization increase of 1,008%.
See below for a brief video regarding SSC's 2024 performance:
Jeff Swainson, SSC President & CEO stated: "We are honoured to have achieved this prestigious ranking on the TSX Venture 50TM. I am incredibly proud of our team, as it was through great industry adversity that we were able to deliver such tremendous results, including four accretive acquisitions, 530% revenue growth between Q4 2023 and Q4 2024, and eight straight quarters of normalized net income profitability. 2024 served to greatly reinforce our foundation, on which we will continue to leverage our track record of consistent positive results, access to capital, and proven ability to transact on highly accretive terms, to capitalize on the many opportunities that the distressed and capital constrained cannabis industry has to offer. I look forward to working with our leadership team, shareholders, and all stakeholders to deliver another tremendous year ahead."
Tim Babcock, President, TSX Venture Exchange, stated: "The performance of the TSX Venture 50 underscores the strategic importance of Canadian natural resources and high-growth innovation. With heightened demand for critical minerals, energy security and transition, and advanced manufacturing, this year's TSX Venture 50 showcases how TSXV is empowering Canadian businesses to raise capital, scale operations, and contribute to a secure and prosperous future for Canada."
Update on Closing of Bio-Tech Acquisition
Due to a procedural delay beyond SSC's control, the closing of the Delta 9 Bio-Tech ("Bio-Tech") acquisition is now estimated to occur during the week of February 24, 2025.
For more details regarding the Bio-Tech acquisition, see SSC's press releases dated February 13, 2025, January 28, 2025, and December 30, 2024, which are available on SSC's SEDAR+ profile at www.sedarplus.ca.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Simply Solventless Concentrates Ltd.
SSC is a public company incorporated under the Business Corporations Act (Alberta) that trades on the TSXV under the ticker symbol HASH. SSC's mission is to provide pure, potent, terpene-rich ready to consume cannabis products to discerning cannabis consumers.
Simply Solventless Concentrates Ltd. Jeff Swainson, President & CEO Phone: 403-796-3640 Email: jeff@simplysolventless.ca
Notice on Forward-Looking Information
This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends", "expects", "projected", "approximately" and similar expressions which are intended to identify forward-looking statements. More particularly and without limitation, this press release contains forward looking statements concerning the expected closing date of the Bio-Tech acquisition. SSC cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material risks, factors, assumptions and expectations, many of which are beyond the control of SSC, including expectations and assumptions concerning SSC, the ability to secure adequate financing on terms acceptable to SSC, the ability to maintain relationships with customers, employees and suppliers, the timing and market acceptance of products, competition in SSC's markets, SSC's reliance on customers, fluctuations in interest rates, SSC's ability to maintain good relations with its customers, employees and other stakeholders, changes in law or regulations, SSC's ability to protect its intellectual property, as well as other risks and uncertainties, including those described in SSC's filings available on SEDAR+ at www.sedarplus.ca. The reader is cautioned that assumptions used in the preparation of any forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of SSC. The reader is cautioned not to place undue reliance on any forward-looking statements. The reader is further cautioned that there is no guarantee that the Bio-Tech acquisition will close at all or on the proposed terms and the closing of the Offering remains subject to the final approval of the TSXV. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
The forward-looking statements contained in this press release are made as of the date of this press release, and SSC does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by securities law.
Not for distribution to U.S. news wire services or for dissemination in the United States.
